10 XP 0   0   5  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Castle Biosciences Inc - Trending symbols

Latest News of Castle Biosciences Inc

DateTitleRead
2025-05-05
22:06
Castle Biosciences Reports First Quarter 2025 ResultsRead
2025-05-05
22:05
Castle Biosciences to Acquire PreviseRead
2025-05-02
22:30
New Data at DDW 2025 Further Demonstrates the TissueCypher® Test's Ability to Identify Patients at Increased Risk for Developing Esophageal CancerRead
2025-04-25
22:15
New Data at AACR Annual Meeting Highlights Use of DecisionDx®-Melanoma to Identify Early-Stage Melanoma Patients at High Risk of Distant MetastasisRead

Notifications

TypeNotificationDate
RSI OversoldOversold RSI (Relative Strength Index)2025-05-07



Trends

 2024-03-312024-06-302024-09-302024-12-312025-03-31
Interest Expense 14256270-69201-10992-109-17
Income Tax Expense 161632739645-1,079-1,034
Income before Tax -18,76111,888-6,8734,332-2,54152-2,48910,3757,886
Net Income -18,77711,872-6,9054,325-2,58046-2,53411,4548,920
Operating Income -21,15711,517-9,6403,982-5,658187-5,47110,4835,012
Tax Provision 161632739645-1,079-1,034
Net Income from Continuing Operations -18,77711,872-6,9054,325-2,58046-2,53411,4548,920
EBIT -18,75811,887-6,8711,213-5,658187-5,47110,4835,012
EBITDA -15,71812,021-3,6971,263-2,434303-2,13110,4918,360
Accumulated Other Comprehensive Income -381245-136-8-14473-71207136

Comments

How you think about this?

Leave a comment

Stay informed about Castle Biosciences Inc.

Receive notifications about Castle Biosciences Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.